The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Less than five years on from when Novo Nordisk's semaglutide drug received FDA approval for weight loss (Wegovy), the Danish pharmaceutical company has announced it will seek regulatory approval ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Amy Schumer revealed she’s on a new weight loss medication ... While both drugs are used to help with weight loss, Mounjaro has been FDA-approved to treat Type II Diabetes, while Wegovy has ...

The newest U.S. wonder drug -- Zepbound -- is extraordinarily effective in driving major weight ... approval times associated with developing new drugs. Instead, they modify patented, FDA-approved ...